DUBLIN--(BUSINESS WIRE)--The "Cardiac Arrhythmia Monitoring Device Market Report By Application, Type, End User, Countries and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.
Cardiac Arrhythmia Monitoring Device Market is expected to be US$ 11.55 billion by 2032 from US$ 6.21 billion in 2023, with a CAGR of 7.14% during 2024 to 2032.
The frequency of cardiac arrhythmia is increasing: The demand for cardiac arrhythmia monitoring devices is on the rise owing to higher incidence of cardiac arrhythmias, longer life expectancy of the global population, and need for advanced monitoring solutions. These tools are very important when it comes to promising diagnosis in the beginning, constant monitoring and timely follow up, hence improving the lot of the patient.
According to the American Heart Association, it is expected that in the year 2035, more than 130 million Americans will be dealing with cardiovascular disease and this has led to the increase in the incidents of cardiac arrhythmia. Thus, they are likely to require constant supervision to avoid heart failure in this population as well as deal with other emergent health conditions. Cardiac arrhythmias indicated in the early phases should be recognized quickly for the prevention of the disappointing function of the heart in patients who already have severe cardiovascular diseases. Thus, monitoring of this vulnerable population is central to the practice, and recent advances of sophisticated monitoring systems underscore the imperative nature of this function in cardiovascular care.
Rising healthcare spending: The overall advancement in the global investment in healthcare has indeed boosted the growth of the cardiac arrhythmia monitoring tool market. In more developed countries the emphasis is made on constant monitoring due to large stakes in modern medical equipment like cardiac monitoring devices. Higher health care expenditures are used to incorporate new monitoring devices which are needed to enhance patient's performance as well as to avoid the development of severe genius seizures and other complications in patients with undiagnosed heart rhythms. Also, increased spending gives the workforce a chance to install effective and modern machines, thus growing the quality of services provided to the patients.
Technological Advancements: Monitoring technology has greatly enhanced the diagnostic procedures as well as the management of patients with cardiac arrhythmias. ILRs, for instance, can be implanted and are mobile, as well as wearable monitors that allow for long term consistent tracking and therefore more precise detection of the arrhythmias and faster creation of treatment strategies. The imposition of wireless connectivity in combination with cloud-based platforms has improved patients' care.
Modern cardiac arrhythmia monitoring devices that have longer battery time and higher accuracy of the data analysis algorithm are becoming more and more useful for patients. This has led to the expected growth in the market and contributes to ongoing research and development activities to cater the growing demand of good monitoring solution around the world.
North America Cardiac Arrhythmia Monitoring Device Market
The North American CAMD market has witnessed much growth and especially the USA being the leading market. Cardiovascular diseases continue to increase in frequency, enhanced monitoring devices become more and more available, and the population ages; these factors create a large trend. Being a country with a highly developed health care system and a significantly high health care cost, the USA has a large and significant role in the advancement and growth of the market. They are Holter monitors, event recorders, implantable loop recorders; All are real-time monitoring system in the diagnosis and management of arrhythmia.
New products such as wireless monitoring and wearable technology have improved the ease of use and adherence to prescribed treatments hence increasing the market potential for the industry. Also, growing knowledge about early diagnosis and prevention has put pressure on the use of such devices. Static key market players are geared towards innovation that comes with improved efficiency and ease of use of the devices. Last but not the least, USA market also benefits from the supportive regulatory laws and reimbursable medical expenses. The North American market is currently on the rise and will open more potential for growth due to advancement in technology and health care.
Cardiac Arrhythmia Monitoring Device Company Analysis
The major players of Cardiac Arrhythmia Monitoring Device Market are Abbott Laboratories, GE Healthcare, Koninklijke Philips N. V, Medtronic PLC, Asahi Kasei Corporation, Boston Scientific Corporation, iRhythm Technologies, and Nihon Kohden. Such companies focus on developing and supplying professional and high-quality cardiac arrhythmia monitoring equipment for practitioners and individuals.
Cardiac Arrhythmia Monitoring Device Company News
In October 2023, Boston Scientific created the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, a next-generation insertable monitor designed for long-term arrhythmia monitoring associated with conditions such as atrial fibrillation (AF), syncope, and cryptogenic stroke.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value (USD) in 2023 | $6.21 Billion |
| Forecasted Market Value (USD) by 2032 | $11.55 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
All the key players have been covered from 4 Viewpoints:
- Abbott Laboratories
- GE healthcare
- Koninklijke Philips N.V.
- Medtronic PLC
- Asahi Kasei Corporation
- Boston scientific corporation
- iRhythm Technologies
- Nihon kohden
- Business Overview
- Product Portfolio
- Recent Development & Strategies
- Revenue Analysis
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenge
5. Global Cardiac Arrthymia Monitoring Device Market
6. Share Analysis
6.1 By Type
6.2 By Application
6.3 By End User
6.4 By Countries
7. Type
7.1 ECG monitors
7.2 Implantable monitors
7.3 Holter monitors
7.4 Mobile cardiac telematory
7.5 Others
8. Application
8.1 Tachycardia
8.2 Atrial Tachycardia
8.3 Ventricular Tachycardia
8.4 Bradycardia
8.5 Premature Contraction
9. End User
9.1 Hospitals & Clinics
9.2 Diagnostic Centers
9.3 Others
10. Countries
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Australia
10.3.6 Thailand
10.3.7 Indonesia
10.3.8 Philippines
10.4 Latin America
10.4.1 Mexico
10.4.2 Brazil
10.4.3 Argentina
10.5 Middle East & Africa
10.5.1 Saudi Arabia
10.5.2 South Africa
10.5.3 UAE
10.5.4 Turkey
10.6 Rest of the world
11. Porter's Five Forces Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat
13. Key Players Analysis
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900